Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Semiconductors & related devices
Sub-IndustrySemiconductors
SectorComputer and Technology
SymbolNASDAQ:IMI
CUSIP45882D10
Phone408-582-5700
Debt
Debt-to-Equity RatioN/A
Current Ratio8.16
Quick Ratio8.16
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$37.20 million
Price / Sales1.58
Cash FlowN/A
Price / CashN/A
Book Value$0.73 per share
Price / Book1.62
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-10,400,000.00
Net Margins-4.76%
Return on Equity-5.07%
Return on Assets-4.16%
Miscellaneous
Employees105
Outstanding Shares49,740,000
Market Cap$61.18 million
Intermolecular (NASDAQ:IMI) Frequently Asked Questions
What is Intermolecular's stock symbol?
Intermolecular trades on the NASDAQ under the ticker symbol "IMI."
How were Intermolecular's earnings last quarter?
Intermolecular Inc (NASDAQ:IMI) posted its earnings results on Monday, August, 6th. The semiconductor company reported $0.01 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.01 by $0.01. The semiconductor company had revenue of $9.80 million for the quarter. Intermolecular had a negative net margin of 4.76% and a negative return on equity of 5.07%. View Intermolecular's Earnings History.
When is Intermolecular's next earnings date?
What price target have analysts set for IMI?
1 Wall Street analysts have issued 1 year price targets for Intermolecular's shares. Their forecasts range from $3.00 to $3.00. On average, they expect Intermolecular's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 153.2% from the stock's current price. View Analyst Price Targets for Intermolecular.
What is the consensus analysts' recommendation for Intermolecular?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intermolecular in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Intermolecular.
Who are some of Intermolecular's key competitors?
Some companies that are related to Intermolecular include Adesto Technologies (IOTS), Pixelworks (PXLW), Kopin (KOPN), GSI Technology (GSIT), Everspin Technologies (MRAM), Sequans Communications (SQNS), EMCORE (EMKR), Resonant (RESN), QuickLogic (QUIK), POET Technologies (POETF), ReneSola (SOL), Atomera (ATOM), Summit Semiconductor (WISA), O2Micro International (OIIM) and LightPath Technologies (LPTH).
Who are Intermolecular's key executives?
Intermolecular's management team includes the folowing people:
- Mr. Christian F. Kramer, Pres, CEO & Director (Age 56)
- Mr. Bill Roeschlein, Sr. VP, CFO & Principal Accounting Officer (Age 48)
- Mr. C. Richard Neely Jr., Consultant (Age 64)
- Mr. Milind Weling, Sr. VP of Programs & Operations
- Dr. Karl Littau, Chief Technology Officer
Has Intermolecular been receiving favorable news coverage?
Media headlines about IMI stock have trended somewhat positive on Wednesday, according to Accern. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intermolecular earned a coverage optimism score of 0.18 on Accern's scale. They also assigned news articles about the semiconductor company an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for Intermolecular.
Who are Intermolecular's major shareholders?
Intermolecular's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.21%) and BlackRock Inc. (0.25%). Company insiders that own Intermolecular stock include Lloyd I Miller III, Rick Neely and William C Martin. View Institutional Ownership Trends for Intermolecular.
Which institutional investors are buying Intermolecular stock?
IMI stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and BlackRock Inc.. Company insiders that have bought Intermolecular stock in the last two years include Lloyd I Miller III and William C Martin. View Insider Buying and Selling for Intermolecular.
How do I buy shares of Intermolecular?
Shares of IMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Intermolecular's stock price today?
One share of IMI stock can currently be purchased for approximately $1.1850.
How big of a company is Intermolecular?
Intermolecular has a market capitalization of $61.18 million and generates $37.20 million in revenue each year. Intermolecular employs 105 workers across the globe.
How can I contact Intermolecular?
Intermolecular's mailing address is 3011 NORTH FIRST STREET, SAN JOSE CA, 95134. The semiconductor company can be reached via phone at 408-582-5700 or via email at [email protected]
MarketBeat Community Rating for Intermolecular (NASDAQ IMI)
MarketBeat's community ratings are surveys of what our community members think about Intermolecular and other stocks. Vote "Outperform" if you believe IMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMI will underperform the S&P 500 over the long term. You may vote once every thirty days.
